Another reason to take over TLN
Two reasons for me writing this current post; annoy Pepman with facts and reality (LOL) and stating the value of TLN based on facts and truth.
In my previous posts, I wrote that Big Pharmas are buying Biotechs to replace cash flow shortfall from patent expiration.
Another reason to buy a company is gain access to cutting edge technology, let's explore this avenue.
4 strategies in seeking cure for cancer
Extra-cellular
1) Using antibody so that autoimmune system kills cancers
2) Blocking, stopping blood flow to cancer cells so that they starve out.
So far, not much success...
Intra-Cellular the new way to attack cancer cells
1) M2PK (232 is the only drug candidate able to do this) - blocking glucose absortion by cancer cell - starving em out
2) Downstream, ras pathway blocking (4601 is one of the few drug candidate able to do this) - putting the switch back on - putting the cell death switch back on.
Thallion is the leader in both of these later field.
Again the idea is to gain access to the sciences. Paying a relative small amout of money (60-70millions) is a good proposition and a strategic fit for a buyer.